These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 7531601)

  • 41. GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder.
    Baiocchi RA; Ward JS; Carrodeguas L; Eisenbeis CF; Peng R; Roychowdhury S; Vourganti S; Sekula T; O'Brien M; Moeschberger M; Caligiuri MA
    J Clin Invest; 2001 Sep; 108(6):887-94. PubMed ID: 11560958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
    Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S
    Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of Epstein-Barr virus-induced lymphoproliferation derived from human peripheral blood mononuclear cells transferred to severe combined immunodeficient mice.
    Okano M; Taguchi Y; Nakamine H; Pirruccello SJ; Davis JR; Beisel KW; Kleveland KL; Sanger WG; Fordyce RR; Purtilo DT
    Am J Pathol; 1990 Sep; 137(3):517-22. PubMed ID: 1975985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis.
    Jäger M; Benninger-Döring G; Prang N; Sylla BS; Laumbacher B; Wank R; Wolf H; Schwarzmann F
    Int J Cancer; 1998 May; 76(5):694-701. PubMed ID: 9610728
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeted activation of human Vγ9Vδ2-T cells controls epstein-barr virus-induced B cell lymphoproliferative disease.
    Xiang Z; Liu Y; Zheng J; Liu M; Lv A; Gao Y; Hu H; Lam KT; Chan GC; Yang Y; Chen H; Tsao GS; Bonneville M; Lau YL; Tu W
    Cancer Cell; 2014 Oct; 26(4):565-76. PubMed ID: 25220446
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epstein-Barr virus, B cell lymphoproliferative disease, and SCID mice: modeling T cell immunotherapy in vivo.
    Johannessen I; Bieleski L; Urquhart G; Watson SL; Wingate P; Haque T; Crawford DH
    J Med Virol; 2011 Sep; 83(9):1585-96. PubMed ID: 21739450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model.
    Hong GK; Gulley ML; Feng WH; Delecluse HJ; Holley-Guthrie E; Kenney SC
    J Virol; 2005 Nov; 79(22):13993-4003. PubMed ID: 16254335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein-Barr virus reactivation.
    Piovan E; Bonaldi L; Indraccolo S; Tosello V; Menin C; Comacchio F; Chieco-Bianchi L; Amadori A
    Leukemia; 2003 Aug; 17(8):1643-9. PubMed ID: 12886254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epstein-Barr virus-associated lymphoproliferative disorders.
    Purtilo DT; Strobach RS; Okano M; Davis JR
    Lab Invest; 1992 Jul; 67(1):5-23. PubMed ID: 1320711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epstein-Barr virus and bone marrow transplantation.
    Caldas C; Ambinder R
    Curr Opin Oncol; 1995 Mar; 7(2):102-6. PubMed ID: 7756374
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cellular immunotherapy with ex vivo expanded cord blood T cells in a humanized mouse model of EBV-associated lymphoproliferative disease.
    Matsuda G; Imadome K; Kawano F; Mochizuki M; Ochiai N; Morio T; Shimizu N; Fujiwara S
    Immunotherapy; 2015; 7(4):335-41. PubMed ID: 25917625
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bcl-2 antisense oligodeoxynucleotide therapy of Epstein-Barr virus-associated lymphoproliferative disease in severe combined immunodeficient mice.
    Guinness ME; Kenney JL; Reiss M; Lacy J
    Cancer Res; 2000 Oct; 60(19):5354-8. PubMed ID: 11034070
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymphoproliferative disease in human peripheral-blood-mononuclear-cell- injected scid mice. II. Role of host and donor factors in tumor generation.
    Veronesi A; Coppola V; Veronese ML; Menin C; Bruni L; D'Andrea E; Mion M; Amadori A; Chieco-Bianchi L
    Int J Cancer; 1994 Dec; 59(5):676-83. PubMed ID: 7960241
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Experimental infection of NOD/SCID mice reconstituted with human CD34+ cells with Epstein-Barr virus.
    Islas-Ohlmayer M; Padgett-Thomas A; Domiati-Saad R; Melkus MW; Cravens PD; Martin Mdel P; Netto G; Garcia JV
    J Virol; 2004 Dec; 78(24):13891-900. PubMed ID: 15564497
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood with hemophagocytic syndrome.
    Chen G; Chen L; Qin X; Huang Z; Xie X; Li G; Xu B
    Int J Clin Exp Pathol; 2014; 7(10):7110-3. PubMed ID: 25400806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epstein-Barr virus-induced human B-cell lymphomas in SCID mice reconstituted with human peripheral blood leukocytes.
    Mosier DE; Picchio GR; Baird SM; Kobayashi R; Kipps TJ
    Cancer Res; 1992 Oct; 52(19 Suppl):5552s-5553s. PubMed ID: 1327510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional diversity of the CD8(+) T-cell response to Epstein-Barr virus (EBV): implications for the pathogenesis of EBV-associated lymphoproliferative disorders.
    Nazaruk RA; Rochford R; Hobbs MV; Cannon MJ
    Blood; 1998 May; 91(10):3875-83. PubMed ID: 9573025
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human immunoglobulin preparations suppress the occurrence of Epstein-Barr virus-associated lymphoproliferation.
    Nadal D; Guzman J; Fröhlich S; Braun DG
    Exp Hematol; 1997 Mar; 25(3):223-31. PubMed ID: 9091298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lymphomagenesis in the SCID-hu mouse involves abundant production of human interleukin-10.
    Baiocchi RA; Ross ME; Tan JC; Chou CC; Sullivan L; Haldar S; Monne M; Seiden MV; Narula SK; Sklar J
    Blood; 1995 Feb; 85(4):1063-74. PubMed ID: 7849294
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.
    Ohshima K; Kimura H; Yoshino T; Kim CW; Ko YH; Lee SS; Peh SC; Chan JK;
    Pathol Int; 2008 Apr; 58(4):209-17. PubMed ID: 18324913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.